About: patient safety
Pharma firms and consumer groups united over EMA relocation
EU leaders should make a patient-oriented decision on the relocation of the European Medicines Agency (EMA) from London and ensure “minimal disruption”, according to the pharmaceutical industry and consumer groups.
EU Parliament demands clarity in public funding of drugs R+D
A European Parliament resolution adopted yesterday (2 March) called for transparency and clarity of public funding on research and development of new drugs, claiming that in such cases public investment should be reflected in the price of drugs.
New medical devices rules should avoid ‘unnecessary’ red tape, industry says
The implementation of new rules on medical devices should avoid extra burdens and unnecessary bureaucracy, health industry officials have told EURACTIV.com.